Literature DB >> 6321794

Limited proteolysis of herpes simplex virus glycoproteins that occurs during their extraction from vero cells.

K M Zezulak, P G Spear.   

Abstract

Herpes simplex virus glycoproteins extracted from infected Vero cells can be smaller in apparent size than the same viral products extracted from infected HEp-2 cells. Here we show that the differences in size result primarily from limited proteolysis, during or after their extraction, of the viral glycoproteins made in Vero cells. In the absence of appropriate protease inhibitors, both mature and immature forms of four different glycoproteins specified by herpes simplex virus type 2 were significantly smaller (based on electrophoretic mobilities in acrylamide gels) when extracted from Vero cells than when extracted from HEp-2 cells. Inclusion of certain protease inhibitors in the extraction buffer, however, permitted isolation of immature forms from Vero cells that were indistinguishable in size from the immature forms extracted from HEp-2 cells. Under these conditions, the mature forms of glycoproteins B and E were also indistinguishable by electrophoretic sizing from those made in HEp-2 cells, whereas the mature forms of glycoproteins D and F were smaller, indicating the possibility of differences between Vero and HEp-2 cells in the post-translational processing of glycoproteins D and F.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321794      PMCID: PMC255607     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

3.  Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins.

Authors:  J M Keller; P G Spear; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

4.  Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2.

Authors:  N Balachandran; D Harnish; R A Killington; S Bacchetti; W E Rawls
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

5.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.

Authors:  L Pereira; D Dondero; B Norrild; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein.

Authors:  K M Zezulak; P G Spear
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

Authors:  N Balachandran; D Harnish; W E Rawls; S Bacchetti
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis.

Authors:  L Pereira; D Dondero; B Roizman
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  19 in total

1.  Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors.

Authors:  D C Johnson; M W Ligas
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

2.  Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.

Authors:  I Sithole; L F Lee; L F Velicer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.

Authors:  W J Weijer; J W Drijfhout; H J Geerligs; W Bloemhoff; M Feijlbrief; C A Bos; P Hoogerhout; K E Kerling; T Popken-Boer; K Slopsema
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Isolation of herpes simplex virus regulatory protein ICP4 as a homodimeric complex.

Authors:  D W Metzler; K W Wilcox
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4.

Authors:  D M Knipe; D Senechek; S A Rice; J L Smith
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

7.  Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

Authors:  H Ghiasi; A B Nesburn; R Kaiwar; S L Wechsler
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells.

Authors:  A K Patick; H C Hinze
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

9.  Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.

Authors:  H Ghiasi; R Kaiwar; S Slanina; A B Nesburn; S L Wechsler
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.